Chen et al. found that the lncRNA CRNDE triggers protective autophagy by upregulating ATG4B in HCC cells via sequestration of miR-543, whereas sorafenib therapy activates the CRNDE/ATG4B/autophagy pathway and reduces sorafenib sensitivity in HCC [86]. Here, ATG4B is linked to hepatocellular carcinoma.